Gąsiorowski K - Search Results

1

The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease.

Chachaj A, Gąsiorowski K, Szuba A, Sieradzki A, Leszek J. Chachaj A, et al. Among authors: gasiorowski k. Curr Neuropharmacol. 2023;21(2):380-391. doi: 10.2174/1570159X20666220411091332. Curr Neuropharmacol. 2023. PMID: 35410605 Free PMC article. Review.

2

Alzheimer's Disease - Future Therapy Based on Dendrimers.

Aliev G, Ashraf GM, Tarasov VV, Chubarev VN, Leszek J, Gasiorowski K, Makhmutovа A, Baeesa SS, Avila-Rodriguez M, Ustyugov AA, Bachurin SO. Aliev G, et al. Among authors: gasiorowski k. Curr Neuropharmacol. 2019;17(3):288-294. doi: 10.2174/1570159X16666180918164623. Curr Neuropharmacol. 2019. PMID: 30227819 Free PMC article. Review.

3

Current and Near-Future Treatment of Alzheimer's Disease.

Gąsiorowski K, Brokos JB, Sochocka M, Ochnik M, Chojdak-Łukasiewicz J, Zajączkowska K, Fułek M, Leszek J. Gąsiorowski K, et al. Curr Neuropharmacol. 2022;20(6):1144-1157. doi: 10.2174/1570159X19666211202124239. Curr Neuropharmacol. 2022. PMID: 34856906 Free PMC article.

4

A proposed new strategy of immunotherapy for Alzheimer's disease.

Gasiorowski K, Leszek J. Gasiorowski K, et al. Med Hypotheses. 1997 Oct;49(4):319-26. doi: 10.1016/s0306-9877(97)90198-5. Med Hypotheses. 1997. PMID: 9352502

5

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players.

Gasiorowski K, Brokos B, Leszek J, Tarasov VV, Ashraf GM, Aliev G. Gasiorowski K, et al. Curr Top Med Chem. 2017;17(12):1429-1437. doi: 10.2174/1568026617666170103161233. Curr Top Med Chem. 2017. PMID: 28049397 Review.

6

Nanotechnology for Alzheimer Disease.

Leszek J, Md Ashraf G, Tse WH, Zhang J, Gasiorowski K, Avila-Rodriguez MF, Tarasov VV, Barreto GE, Klochkov SG, Bachurin SO, Aliev G. Leszek J, et al. Among authors: gasiorowski k. Curr Alzheimer Res. 2017;14(11):1182-1189. doi: 10.2174/1567205014666170203125008. Curr Alzheimer Res. 2017. PMID: 28164767 Review.

7

Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease.

Leszek J, Sochocka M, Gąsiorowski K. Leszek J, et al. Among authors: gasiorowski k. J Neurol Sci. 2012 Dec 15;323(1-2):25-32. doi: 10.1016/j.jns.2012.09.010. Epub 2012 Sep 29. J Neurol Sci. 2012. PMID: 23026534 Review.

8

Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: a new approach to therapy.

Sochocka M, Koutsouraki ES, Gasiorowski K, Leszek J. Sochocka M, et al. Among authors: gasiorowski k. CNS Neurol Disord Drug Targets. 2013 Sep;12(6):870-81. doi: 10.2174/18715273113129990072. CNS Neurol Disord Drug Targets. 2013. PMID: 23469836 Review.

9

Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary approaches.

Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, Gąsiorowski K, Leszek J, Aliev G. Sieradzki A, et al. Among authors: gasiorowski k. CNS Neurol Disord Drug Targets. 2011 Mar;10(2):175-83. doi: 10.2174/187152711794480410. CNS Neurol Disord Drug Targets. 2011. PMID: 21222633 Review.

10

Nuclear Envelope and Nuclear Pore Complexes in Neurodegenerative Diseases-New Perspectives for Therapeutic Interventions.

Hachiya N, Sochocka M, Brzecka A, Shimizu T, Gąsiorowski K, Szczechowiak K, Leszek J. Hachiya N, et al. Among authors: gasiorowski k. Mol Neurobiol. 2021 Mar;58(3):983-995. doi: 10.1007/s12035-020-02168-x. Epub 2020 Oct 17. Mol Neurobiol. 2021. PMID: 33067781 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters